There are also other Gln transporters, including SLC6A14 and SLC38A5, reported to be upregulated in various tumor types (for SLC6A14: cervical cancer [71], colorectal cancer [72], estrogen-receptor-positive breast cancer [73], and pancreatic cancer [68]; for SLC38A5: TNBC [69] and pancreatic cancer [70]) and contributing to the overall Gln pool, which further highlights the importance of this nutrient in cancer cell metabolism. Here, SLC38A5 is linked to pancreatic neoplasm.